DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Barlesi F. et al.
Assessment of health-related quality of life (HRQoL) in KEYNOTE-010: A phase 2/3 study of pembrolizumab vs docetaxel in patients with previously treated advanced NSCLC.
Annals of Oncology 2016;
27 (Suppl. 06) vi416-vi454, 1219P
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.